Marx Biotechnology

Blood Test for Graft-versus-host Disease

Health Tech & Life Sciences
Active
Seed Jerusalem, Israel Founded 2011
Last updated 2026-06-18
Total raised
$1.2M
Last: Grant 2019-09
Stage
Seed
Founded
2011
Headcount
2
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences

About

Marx Biotechnology (MBT) develops a blood test to diagnose the early onset of graft-versus-host disease (GVHD) in order to save lives, reduce costs, and improve patient care, allowing doctors to make quick, accurate, and efficient decisions on how best to manage and treat their patients. MBT's blood test will diagnose the early onset of GVHD by monitoring functions on a molecular level that have to change for the disease to occur. The test provides results to physicians within two hours. MBT's big data platform uses a blood test to diagnose numerous diseases, monitor the patient's condition, and indicate what is causing the problem and the best way to treat it.

Funding history · 4 rounds · $1.2M total

2019-09
Grant $50K
2019-06
$325K
2014-11
$245K
2014-03

Q&A

What is Marx Biotechnology's primary focus?
Marx Biotechnology (MBT) develops a blood test to diagnose the early onset of graft-versus-host disease (GVHD) to improve patient care and reduce costs.
How many employees does Marx Biotechnology have?
Marx Biotechnology has 1-10 employees.
When was Marx Biotechnology founded?
Marx Biotechnology was founded in January 2011.
What is Marx Biotechnology's total funding to date?
Marx Biotechnology has raised a total of $1,215,000 USD.
When was Marx Biotechnology's most recent funding round?
Marx Biotechnology's most recent funding round was a Grant in September 2019, with EU Horizon 2020 as an investor.
Who is the founder and CEO of Marx Biotechnology?
Stephen Marx Ph.D. is the Founder & CEO of Marx Biotechnology.
What is the product stage of Marx Biotechnology's offerings?
Marx Biotechnology's product is currently in the R&D stage.
Does Marx Biotechnology hold any patents?
Yes, Marx Biotechnology holds 1 patent.

Team · 1

Founder · Founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

medical-devicesdiagnosticsantibodieshospitalslaboratoriesdoctorsbiotechnologybiomarkersbig-datablood-testinflammatory-diseasesnon-invasivecancer
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)